Leadership Team

Our senior managers and executives were trained in the West, have worked for big western pharmaceutical companies, and are committed to bringing the best clinical practices to China.

Xu Yu

Xu Yu

Founder,
Chief Executive Officer

Daniel Liu, PhD

Daniel Liu, PhD

Chairman,
Chief Scientific Officer

XiuLan Han, MD

XiuLan Han, MD

Founder,
Chief Compliance Officer

Chun Xu, MD, PhD

Chun Xu, MD, PhD

Chief Medical Officer,
General Manager,
Suzhou Clinical Service Center

YuMin LI

YuMin LI

Senior Vice President,
Regulatory Affairs

Theresa TAO

Theresa TAO

Senior Vice President,
Drug Information

Richard Tadd Vice President Global Business Development.

Richard Tadd

Vice President
Global Business Development

YuQing DAI, PhD

YuQing DAI, PhD

Senior Principal Biostatistician
Meta Clinical Technology

Murphy LIU, MD

Murphy LIU, MD

Executive Director,
Medical and Clinical Strategy

Lei ZHANG, MD, PhD

Lei ZHANG, MD, PhD

Director,
Medical Affairs

Lei XU, MD

Lei XU, MD

Director,
Pharmacovigilance

HuaLong Sun, MD, PhD

HuaLong Sun, MD, PhD

General Manager,
Meta Clinical Technology

QiKui Xia, MD

QiKui Xia, MD

General Manager,
Clinical Operation Center

 
 

More About the Clinical Service Center CRO

OUR LEADERSHIP TEAM

Leadership

Our senior managers and executives were trained in the West, have worked for big Western pharmaceutical companies, and are committed to bringing the best clinical practices to China.

Learn more

OUR HISTORY

Company News

For more than a decade, Clinical Service Center-“CSC” (formerly Beijing Clinical Service Center – “BCSC”) has been conducting top-quality clinical trial services in China for pharmaceutical, biotech, and medical device companies the world over.

Learn more

FULL SERVICE PLUS

Full Service Plus

At CSC we define our business scope as “full-service plus” because we go above and beyond the requirements of a traditional full-service CRO to provide you with the end-to-end services you require to get your product in to the China market.

Learn more

Sign up to Receive Company News & China Market Intelligence Updates